Introduction: Ovarian reserve depends on the size and quality of oocytes stored in ovary. Aging and some diseases reduce ovarian reserve, leading to decreased reproductive performance. Laparoscopic surgery is used to treat infertility in women with PCOS. The purpose of this study was measurement of...

Full description

Bibliographic Details
Main Authors:	Laya Farzadi, Mohammad Nouri, Morteza Ghojazadeh, Mona Mohiti, Esmat Aghadavod
Format:	Article
Language:	English
Published:	Tabriz University of Medical Sciences 2012-06-01
Series:	BioImpacts
Subjects:	Ovarian Reserve Laparoscopy Anti-Mullerian Hormone Polycystic Ovary Syndrome
Online Access:	http://dx.doi.org/10.5681/bi.2012.018

Similar Items

Evaluation of relationship between serum levels of anti-müllerian hormone, androgen, and insulin resistant with retrieval oocytes in overweight patients with polycystic ovary syndrome
by: Esmat Aghadavod, et al.
Published: (2015-01-01)

Anti-Müllerian hormone: plasma levels in women with polycystic ovary syndrome and with premature ovarian failure
by: Piotr Skałba, et al.
Published: (2011-06-01)

Establishing an Anti-Müllerian hormone cutoff for diagnosis of polycystic ovarian syndrome in women of reproductive age-bearing Indian ethnicity using the automated Anti-Müllerian hormone assay
by: Nalini Mahajan, et al.
Published: (2019-01-01)

Comparison of Laparoscopic Ovarian Drilling Success between Two Standard and Dose-Adjusted Methods in Polycystic Ovary Syndrome: A Randomized Clinical Trial
by: Leili Hafizi, et al.
Published: (2020-01-01)

Ovarian function after the use of various hemostatic techniques during treatment for endometrioma: protocol for a randomized clinical trial
by: Raquel Silveira da Cunha Araujo, et al.
Published: (2019-07-01)

Relationship between Serum Levels of Anti-Mullerian Hormone, Adiponectin and Oxidative Stress Markers in Patients with Polycystic Ovary Syndrome
by: Mozhgan Kohzadi, et al.
Published: (2020-04-01)

Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome
by: Chan-Hong Park, et al.
Published: (2020-01-01)

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
by: Ran Y, et al.
Published: (2021-03-01)

OVARIAN RESERVE IN THE WOMEN OF LATE REPRODUCTIVE AGE AFTER CONSERVATIVE TREATMENT OF POLYCYSTIC OVARIAN SYNDROME (PCOS) IN ADOLESCENCE
by: K. G. Beltadze, et al.
Published: (2016-06-01)

Anti-Müllerian hormone in polycystic ovary syndrome and normo-ovulatory women: Correlation with clinical, hormonal and ultrasonographic parameters
by: Adel F. Begawy, et al.
Published: (2010-10-01)

Effect of metformin on the anti-Müllerian hormone level in infertile women with polycystic ovarian syndrome
by: Fatemeh Foroozanfard,, et al.
Published: (2017-12-01)

Correlation of phenotypes of polycystic ovarian syndrome with anti-Müllerian hormone levels
by: R Santhiya, et al.
Published: (2021-01-01)

Anti-Müllerian hormone as an indicator of reproductive health in women with obesity and concomitant polycystic ovary syndrome
by: A K Durmanova, et al.
Published: (2016-12-01)

بررسی ارزش تشخیصی نشانگر آنتی‌مولرین هورمون در پیش‌گویی پاسخ به درمان نازایی مبتلایان به سندرم تخمدان پلی‌کیستیک
by: Ferdous Mehrabian, et al.
Published: (2016-11-01)

Concentration of anti-Mullerian hormone in the blood as a result of electrical stimulation of polycystic ovaries in women with infertility
by: Arystanbek O. Atykanov, et al.
Published: (2019-10-01)

Does laparoscopic hysterectomy + bilateral salpingectomy decrease the ovarian reserve more than total abdominal hysterectomy? A cohort study, measuring anti-Müllerian hormone before and after surgery
by: Zohreh Tavana, et al.
Published: (2021-09-01)

Correlation of anti-Müllerian hormone levels with metabolic syndrome events in polycystic ovary syndrome: A cross-sectional study
by: Budi Wiweko, et al.
Published: (2020-03-01)

Expression of the anti-Mullerian hormone, kisspeptin 1, and kisspeptin 1 receptor in polycystic ovary syndrome and controlled ovarian stimulation rat models
by: Ali Risvanli, et al.
Published: (2019-11-01)

Oligo/Amenorrhea Is an Independent Risk Factor Associated With Low Ovarian Response
by: Kai-Lun Hu, et al.
Published: (2021-06-01)

Serum vitamin D levels and ovarian reserve markers in secondary amenorrhea patients: Is there a link?
by: Gyung-Mee Kim, et al.
Published: (2020-07-01)

Evaluation of ultrasonographic and Anti-Müllerian Hormone (AMH) changes as predictors for ovarian reserve after laparoscopic ovarian drilling for women with polycystic ovarian syndrome
by: Emad M. Seyam, et al.
Published: (2014-12-01)

Age related endocrine patterns observed in polycystic ovary syndrome patients vs. ovulatory controls: descriptive data from a university based infertility center
by: Batool Hossein Rashidi, et al.
Published: (2016-10-01)

Interpretation of androgen and anti-Mullerian hormone profiles in a Hispanic cohort of 5- to 8-year-old girls with premature adrenarche
by: Preneet Cheema Brar, et al.
Published: (2018-12-01)

Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS
by: Martina Capuzzo, et al.
Published: (2021-02-01)

Comparison of the umbilical cord Blood’s anti-Mullerian hormone level in the newborns of mothers with polycystic ovary syndrome (PCOS) and healthy mothers
by: Faezeh Tadaion Far, et al.
Published: (2019-11-01)

Efficacy of electroacupuncture in regulating the imbalance of AMH and FSH to improve follicle development and hyperandrogenism in PCOS rats
by: Yin Shi, et al.
Published: (2019-05-01)

Effect of insulin sensitizers on raised serum anti-mullerian hormone levels in infertile women with polycystic ovarian syndrome
by: Neeti Chhabra, et al.
Published: (2018-01-01)

Potential application of anti-müllerian hormone in polycystic ovary syndrome according to chinese classification criteria: A retrospective analysis
by: Ling-Li Tang, et al.
Published: (2020-01-01)

Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels
by: Aliye Nigar Serin, et al.
Published: (2021-03-01)

Anti-Mullerian Hormone as A Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients
by: Parvin Fallahi, et al.
Published: (2011-11-01)

Anti-Mullerian Hormone as a Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients
by: Ashraf Aleyasin, et al.
Published: (2011-11-01)

Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms
by: Nada Ahmed, et al.
Published: (2019-10-01)

Anti-müllerian hormone level in patients with polycystic ovary syndrome
by: Salar Mohammed Saadullah, et al.
Published: (2018-01-01)

Anti-Mullerian Hormone (AMH) as a Predictor of Ovarian Response to Clomiphene Citrate in Polycystic Ovarian Syndrome
by: Serajoom Munira, et al.
Published: (2021-09-01)

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
by: Didier Dewailly, et al.
Published: (2020-09-01)

Anti-Müllerian hormone as a diagnostic marker in Egyptian infertile polycystic ovary syndrome females: Correlations with Vitamin D, total testosterone, dyslipidemia and anthropometric parameters
by: Bakeer Engy, et al.
Published: (2018-01-01)

The association between anti-Müllerian hormone and vitamin 25(OH)D serum levels and polycystic ovarian syndrome in adolescent females
by: Samantha Simpson, et al.
Published: (2020-11-01)

Undetectable Serum Levels of Anti-Müllerian Hormone in Women with Ovarian Hyperstimulation Syndrome during In Vitro Fertilization and Successful Pregnancy Outcome: Case Report
by: Ivana Zec, et al.
Published: (2018-01-01)

Persistent organic pollutants and the size of ovarian reserve in reproductive-aged women
by: Richelle D. Björvang, et al.
Published: (2021-10-01)

Modern approaches to diagnostics of hyperandrogenism distributed forms in reproductive aged women
by: О. А. Бурка, et al.
Published: (2019-05-01)

Cannot write session to /tmp/vufind_sessions/sess_06psui3o9jqm61me2j268v4per